Inicio

International

InternationalInternational

The CRG has a successful track-record for securing support from prestigious international public and private funding agencies, which highlights the genuine scientific contributions of the Institute. This section shows a short selection of ongoing projects, of which some involve participation in distinguished international consortia.

TAONas-LUAD

Therapeutic Antisense Oligonucleotides Targeting NUMB Alternative Splicing in Lung Adenocarcinoma
Principal Investigator/s
Juan Valcárcel, Coordinator
Field / Programme
Genome Biology
Start: 01/04/2022 End: 31/12/2025
Partners
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
SINTEF AS
CARTAGO VENTURES SL (INVENIAM)
More

UNLEASH

Harnessing the splicing code for targeted control of gene expression
Principal Investigator/s
Juan Valcárcel, Coordinator
Field / Programme
Genome Biology
Start: 01/06/2023 End: 31/05/2029
Partners
Helmholtz Zentrum München
University of Dundee
More

NONAME2

Generation of optimised anti-tumor drugs targeting the spliceosome of optimised anti-tumor drugs targeting the spliceosome
Principal Investigator/s
Juan Valcárcel, Project leader
Field / Programme
Genome Biology
Start: 01/12/2022 End: 30/11/2025
More

NONAME3

Single cell multi-omics for the identification of preventative and diagnostic strategies for clonal hematopoiesi
Principal Investigator/s
Lars Velten, Project leader
Field / Programme
Computational Biology and Health Genomics
Start: 01/12/2022 End: 30/11/2025
More

Páginas